Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Springworks Therapeutics Inc (SWTX)

Springworks Therapeutics Inc (SWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Springworks Therapeutics Inc 100 WASHINGTON BOULEVARD STAMFORD CT 06902 USA

www.springworkstx.com Employees: 368 P: 203-883-9490

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

SpringWorks Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing life-changing medicines for patients with severe rare diseases and cancer. The company's product pipeline consists of Nirogacestat and Mirdametinib which are in clinical stage. SpringWorks Therapeutics Inc. is based in Stamford, United States.

Key Statistics

Overview:

Market Capitalization, $K 3,540,650
Enterprise Value, $K 3,470,900
Shares Outstanding, K 75,349
Annual Sales, $ 191,590 K
Annual Net Income, $ -258,130 K
Last Quarter Sales, $ 49,090 K
Last Quarter Net Income, $ -83,190 K
EBIT, $ -264,740 K
EBITDA, $ -261,270 K
60-Month Beta 0.70
% of Insider Shareholders 7.83%
Float, K 69,449
% Float 92.17%
Short Volume Ratio 0.12

Growth:

1-Year Return 24.74%
3-Year Return 61.20%
5-Year Return 22.37%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 1.97%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.11 on 05/09/25
Next Earnings Date 08/06/25
Earnings Per Share ttm -3.41
EPS Growth vs. Prev Qtr -6.73%
EPS Growth vs. Prev Year 5.93%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

SWTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -51.10%
Return-on-Assets % -43.80%
Profit Margin % -134.73%
Debt/Equity 0.00
Price/Sales 18.48
Price/Cash Flow N/A
Price/Book 8.44
Book Value/Share 5.57
Interest Coverage -0.01
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar